These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 14564327
21. A comparison of one-year outcome in adult patients with heart failure in two medical setting: heart failure clinic and daily physician practice. Kanoksilp A, Hengrussamee K, Wuthiwaropas P. J Med Assoc Thai; 2009 Apr; 92(4):466-70. PubMed ID: 19374295 [Abstract] [Full Text] [Related]
22. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care) multicenter, randomized trial. Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, Krum H, Newton PJ, Reid C, Chan YK, Scuffham PA. J Am Coll Cardiol; 2012 Oct 02; 60(14):1239-48. PubMed ID: 23017533 [Abstract] [Full Text] [Related]
23. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators. J Am Coll Cardiol; 2008 Jul 29; 52(5):347-56. PubMed ID: 18652942 [Abstract] [Full Text] [Related]
24. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, Pfisterer M, TIME-CHF-Investigators. Am Heart J; 2006 May 29; 151(5):949-55. PubMed ID: 16644310 [Abstract] [Full Text] [Related]
25. Usefulness of a home-based exercise program for overweight and obese patients with advanced heart failure. Evangelista LS, Doering LV, Lennie T, Moser DK, Hamilton MA, Fonarow GC, Dracup K. Am J Cardiol; 2006 Mar 15; 97(6):886-90. PubMed ID: 16516595 [Abstract] [Full Text] [Related]
26. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH, Acorn Trial Principal Investigators and Study Coordinators. J Thorac Cardiovasc Surg; 2006 Sep 15; 132(3):568-77, 577.e1-4. PubMed ID: 16935112 [Abstract] [Full Text] [Related]
27. [Specialized care program for end-stage heart failure patients. Initial experience in a heart failure unit]. Roig E, Pérez-Villa F, Cuppoletti A, Castillo M, Hernández N, Morales M, Betriu A. Rev Esp Cardiol; 2006 Feb 15; 59(2):109-16. PubMed ID: 16540031 [Abstract] [Full Text] [Related]
28. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group. Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095 [Abstract] [Full Text] [Related]
29. Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure. Woo MA, Moser DK, Stevenson LW, Stevenson WG. Am J Crit Care; 1997 Sep 02; 6(5):348-54. PubMed ID: 9283671 [Abstract] [Full Text] [Related]
30. Telecardiology for patients with chronic heart failure: the 'SHL' experience in Israel. Roth A, Kajiloti I, Elkayam I, Sander J, Kehati M, Golovner M. Int J Cardiol; 2004 Oct 02; 97(1):49-55. PubMed ID: 15336806 [Abstract] [Full Text] [Related]
31. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ, Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators. Arch Intern Med; 2008 Feb 11; 168(3):316-24. PubMed ID: 18268174 [Abstract] [Full Text] [Related]
32. Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management. Singer AJ, Birkhahn RH, Guss D, Chandra A, Miller CD, Tiffany B, Levy P, Dunne R, Bastani A, Thode HC, Hollander JE. Circ Heart Fail; 2009 Jul 11; 2(4):287-93. PubMed ID: 19808351 [Abstract] [Full Text] [Related]
33. [New multidisciplinary heart failure care program (six-month preliminary observation)]. Wierzchowiecki M, Poprawski K, Nowicka A, Kandziora M, Piatkowska A, Jankowiak M, Michałowicz B, Stawski W, Kaszuba D. Pol Merkur Lekarski; 2006 Dec 11; 21(126):511-5. PubMed ID: 17405287 [Abstract] [Full Text] [Related]
34. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M, Petri G, Fabrizi L, Caroselli A, Venusti R, Chiantera A, Giulivi A, Giovannini E, Leggio F. J Cardiovasc Med (Hagerstown); 2007 May 11; 8(5):324-9. PubMed ID: 17443097 [Abstract] [Full Text] [Related]
35. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators. Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343 [Abstract] [Full Text] [Related]
36. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience. Sunsaneewitayakul B, Sitthisook S, Sangwatanaroj S, Prechawat S, Songmuang SB. J Med Assoc Thai; 2007 Jul 29; 90(7):1458-66. PubMed ID: 17710992 [Abstract] [Full Text] [Related]
37. Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial. Torre-Amione G, Sestier F, Radovancevic B, Young J. J Am Coll Cardiol; 2004 Sep 15; 44(6):1181-6. PubMed ID: 15364317 [Abstract] [Full Text] [Related]
38. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D, REMATCH Investigators. Circulation; 2004 Aug 24; 110(8):975-81. PubMed ID: 15313942 [Abstract] [Full Text] [Related]
39. A randomized, controlled trial of comprehensive geriatric assessment and multidisciplinary intervention after discharge of elderly from the emergency department--the DEED II study. Caplan GA, Williams AJ, Daly B, Abraham K. J Am Geriatr Soc; 2004 Sep 24; 52(9):1417-23. PubMed ID: 15341540 [Abstract] [Full Text] [Related]
40. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Pires LA, Abraham WT, Young JB, Johnson KM, MIRACLE and MIRACLE-ICD Investigators. Am Heart J; 2006 Apr 24; 151(4):837-43. PubMed ID: 16569543 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]